Insight Molecular Diagnostics (IMDX) Gains from Sales and Divestitures (2023 - 2024)
Insight Molecular Diagnostics (IMDX) posted Gains from Sales and Divestitures of -$169,000 for FY2024, compared with -$1.52 million in FY2023.
Powered by 
Analysis
Insight Molecular Diagnostics (IMDX) Gains from Sales and Divestitures (2023 - 2024) Analysis & Trends
- Business Quant data shows IMDX's Gains from Sales and Divestitures at -$1.52 million in FY2023 and -$25.87 million in FY2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 242.18 Bn | 221.33 Bn | 4.88 Bn |
| 2 | Abbott Laboratories | 168.71 Bn | 139.79 Bn | 7.27 Bn |
| 3 | Danaher | 150.46 Bn | 134.27 Bn | 3.61 Bn |
| 4 | Intuitive Surgical | 138.71 Bn | 118.26 Bn | 1.96 Bn |
| 5 | Medtronic | 110.54 Bn | 76.41 Bn | 6.34 Bn |
| 6 | Stryker | 105.66 Bn | 91.78 Bn | 4.50 Bn |
| 7 | Boston Scientific | 61.74 Bn | 56.75 Bn | 3.85 Bn |
| 8 | Edwards Lifesciences | 49.09 Bn | 33.21 Bn | 1.35 Bn |
| 9 | Becton Dickinson | 48.16 Bn | 45.31 Bn | 2.32 Bn |
| 10 | Insight Molecular Diagnostics | 112.22 Mn | 35.94 Mn | 157,000.00 |
API Access
Insight Molecular Diagnostics Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=IMDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "IMDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=IMDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();